Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care

with No hi ha comentaris
  • Alejandre, C., Penela-Sánchez, D., Alsina, J., Agüera, M., Soler, A., Moussalam, S., Muñoz-Almagro, C., Brotons, P., Cambra, F. J., Forner, O. R., Balaguer, M., Launes, C., & Jordan, I. (2024). Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05634-z (En premsa)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *